Jan Leipe

3.9k total citations
88 papers, 2.4k citations indexed

About

Jan Leipe is a scholar working on Immunology, Rheumatology and Oncology. According to data from OpenAlex, Jan Leipe has authored 88 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Immunology, 27 papers in Rheumatology and 23 papers in Oncology. Recurrent topics in Jan Leipe's work include Cancer Immunotherapy and Biomarkers (16 papers), Rheumatoid Arthritis Research and Therapies (16 papers) and Autoimmune and Inflammatory Disorders Research (14 papers). Jan Leipe is often cited by papers focused on Cancer Immunotherapy and Biomarkers (16 papers), Rheumatoid Arthritis Research and Therapies (16 papers) and Autoimmune and Inflammatory Disorders Research (14 papers). Jan Leipe collaborates with scholars based in Germany, United States and United Kingdom. Jan Leipe's co-authors include Hendrik Schulze‐Koops, Alla Skapenko, Peter E. Lipsky, Claudia Dechant, Mathias Grünke, Christiane Reindl, Axel J. Hueber, Iain B. McInnes, Shauna Kerr and Ashley M. Miller and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

In The Last Decade

Jan Leipe

77 papers receiving 2.3k citations

Peers

Countries citing papers authored by Jan Leipe

Since Specialization

Citations

This map shows the geographic impact of Jan Leipe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Leipe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Leipe more than expected).

Fields of papers citing papers by Jan Leipe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Leipe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Leipe. The network helps show where Jan Leipe may publish in the future.

Co-authorship network of co-authors of Jan Leipe

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Leipe. A scholar is included among the top collaborators of Jan Leipe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Leipe. Jan Leipe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cardiovascular risk assessment enhanced by automated machine learning in a multi-phase study 2025 ·Scientific Reports ·(unknown), (unknown), Philipp Blanke, (unknown), (unknown), (unknown), Jan Leipe, Winfried März, Ksenija Stach, Victor Olsavszky	0
2	Predictors of adherence to a digital health application in patients with inflammatory arthritis: retrospective analysis 2025 ·Rheumatology International ·(unknown), (unknown), (unknown), (unknown), Johannes Knitza, Jan Leipe	0
3	Emerging mechanisms and therapeutics in inflammatory muscle diseases 2025 ·Trends in Pharmacological Sciences ·Sven Wischnewski, (unknown), Chiseko Ikenaga, Jan Leipe, Thomas E. Lloyd, Lucas Schirmer	4
4	Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer: recommendations from the International Society of Geriatric Oncology (SIOG) 2025 ·The Lancet Oncology ·(unknown), Nina Rosa Neuendorff, (unknown), Jan Leipe, (unknown), Christine Sam, Nienke A. de Glas, (unknown), Beverly Canin, Fábio Gomes, Lore Decoster, Beatriz Korc‐Grodzicki, Siri Rostoft, Nicolò Matteo Luca Battisti, Hans Wildiers	6
5	Digital Translation Platform (Translatly) to Overcome Communication Barriers in Clinical Care: Pilot Study 2024 ·JMIR Formative Research ·Victor Olsavszky, (unknown), (unknown), (unknown), Fabian Finkelmeier, Mireen Friedrich‐Rust, Stefan Zeuzem, Eva Herrmann, Jan Leipe, (unknown), (unknown), (unknown)	1
6	Severe Leptospirosis with Acute Kidney Injury: A Case Description and Literature Review 2024 ·The Nephron journals/Nephron journals ·(unknown), (unknown), Matthias Jung, (unknown), Gökhan Yücel, Faeq Husain‐Syed, Jan Leipe, Bernhard K. Krämer, (unknown)	0
7	Sex and anti-inflammatory treatment affect outcome of melanoma and non-small cell lung cancer patients with rheumatic immune-related adverse events 2023 ·Journal for ImmunoTherapy of Cancer ·(unknown), L. Diekmann, (unknown), (unknown), Manuel Feißt, Victor Olsavszky, (unknown), Hanns‐Martin Lorenz, Margarida Souto‐Carneiro, Jessica C. Hassel, Petros Christopoulos, Jan Leipe	2
8	Chronische Entzündungserkrankungen in Deutschland 2023 ·Zeitschrift für Rheumatologie ·Jan Leipe, Renate Schmelz, Gabriela Riemekasten, Diamant Thaçi, Jörg Henes, Knut Schäkel, Andreas Pinter, Michael Sticherling, Joanna Wegner, Stefano Fusco, (unknown), (unknown), (unknown), Holger Bartz, (unknown), Sandra Schmidt, Bimba F. Hoyer	3
9	Lipopolysaccharide Tolerance in Human Primary Monocytes and Polarized Macrophages 2023 ·International Journal of Molecular Sciences ·Hui Li, Annette Breedijk, Nadine Dietrich, Katja Nitschke, (unknown), Philipp Nuhn, Bernhard K. Krämer, Benito Yard, Jan Leipe, Sibylle J. Hauske	6
10	Comparison of physician and artificial intelligence-based symptom checker diagnostic accuracy 2022 ·Rheumatology International ·(unknown), Johannes Knitza, Jan Leipe, Martin Krusche, Martin Welcker, Sebastian Kühn, Johanna Mücke, Axel J. Hueber, (unknown), Philipp Klemm, Stefan Kleinert, Peer Aries, Nicolas Vuillerme, David Simón, Arnd Kleyer, Georg Schett, Johanna Callhoff	31
11	1809O TRheuMa registry provides real world data on rheumatic immune-related adverse events 2020 ·Annals of Oncology ·Karolina Benesova, L. Diekmann, H.-M. Lorenz, Jan Leipe, Joachim B. Kunz, J.C. Hassel, Karin Jordan	0
12	Aktuelle Handlungsempfehlungen der Deutschen Gesellschaft für Rheumatologie für die Betreuung von Patienten mit rheumatischen Erkrankungen während der SARS-CoV‑2/Covid 19-Pandemie 2020 ·Zeitschrift für Rheumatologie ·(unknown), Hendrik Schulze‐Koops, Julia U. Holle, Frank Moosig, Christof Specker, Peer Aries, Gerd R Burmester, Christoph Fiehn, Bimba F. Hoyer, Andreas Krause, Jan Leipe, (unknown), M. Schneider, Philipp Sewerin, (unknown), (unknown), K. Krüger, Christof Iking‐Konert	9
13	SARS-CoV-2 & Rheuma 2020 ·Zeitschrift für Rheumatologie ·Jan Leipe, Bimba F. Hoyer, Christof Iking‐Konert, Hendrik Schulze‐Koops, Christof Specker, K. Krüger	2
14	Nebenwirkungsmanagement in der Immunonkologie : Praktische Aspekte im Management immunvermittelter Nebenwirkungen unter immunonkologischer Therapie 2019 ·DMW - Deutsche Medizinische Wochenschrift ·Niels Reinmuth, Michael Bitzer, Barbara Deschler-Baier, Jürgen R. Fischer, Jonas Kuon, Jan Leipe, Justyna Rawluk, Christian Schulz, Claus Peter Heußel, Michael Schultheiß	1
15	Long- and short-term association of low-grade systemic inflammation with cardiovascular mortality in the LURIC study 2019 ·Clinical Research in Cardiology ·(unknown), Hubert Scharnagl, Marcus E. Kleber, Christian Windpassinger, Wolfgang Sattler, Jan Leipe, Bernhard K. Krämer, Winfried März, Ernst Malle	17
16	Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions 2017 ·Cancer Treatment Reviews ·Jessica C. Hassel, Lucie Heinzerling, Jens Aberle, Oliver Bähr, Thomas Eigentler, Marc‐Oliver Grimm, (unknown), Jan Leipe, Niels Reinmuth, Julia K. Tietze, Jörg Trojan, Lisa Zimmer, Ralf Gutzmer	237
17	Activation of pregnane X receptor inhibits experimental dermal fibrosis 2013 ·Annals of the Rheumatic Diseases ·Christian Beyer, Alla Skapenko, Alfiya Distler, Clara Dees, (unknown), Luis E. Muñoz, Jan Leipe, Hendrik Schulze‐Koops, Oliver Distler, Georg Schett, Jörg H. W. Distler	24
18	Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis 2011 ·Annals of the Rheumatic Diseases ·Jan Leipe, (unknown), Mathias Grünke, (unknown), Claudia Dechant, Axel Nigg, M. Witt, Volker Vielhauer, Christiane Reindl, Hendrik Schulze‐Koops, Alla Skapenko	86
19	Cutting Edge: Mast Cells Express IL-17A in Rheumatoid Arthritis Synovium 2010 ·The Journal of Immunology ·Axel J. Hueber, Darren L. Asquith, Ashley M. Miller, (unknown), Shauna Kerr, Jan Leipe, Alirio J. Melendez, Iain B. McInnes	304
20	GATA-3 in Human T Cell Helper Type 2 Development 2004 ·The Journal of Experimental Medicine ·Alla Skapenko, Jan Leipe, Uwe Niesner, Koenraad Devriendt, Rolf Beetz, Andreas Radbruch, Joachim R. Kalden, Peter E. Lipsky, Hendrik Schulze‐Koops	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact